These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6968745)

  • 1. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four further antibiotics related to olivanic acid produced by Streptomyces olivaceus: fermentation, isolation, characterisation and biosynthetic studies.
    Box SJ; Hood JD; Spear SR
    J Antibiot (Tokyo); 1979 Dec; 32(12):1239-47. PubMed ID: 317283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.
    Butterworth D; Cole M; Hanscomb G; Rolinson GN
    J Antibiot (Tokyo); 1979 Apr; 32(4):287-94. PubMed ID: 468715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.
    Hood JD; Box SJ; Verrall MS
    J Antibiot (Tokyo); 1979 Apr; 32(4):295-304. PubMed ID: 468716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
    Coleman K; Griffin DR; Page JW; Upshon PA
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of BRL 42715, a beta-lactamase-inhibiting penem.
    Qadri SM; Ueno Y; Burdette M; Kroschinsky R; Almodovar E
    Chemotherapy; 1991; 37(6):398-404. PubMed ID: 1760938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F; Saino Y; Koshi T; Hattori Y; Nakayama M; Iwasaki A; Mori T; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative biological properties of some synthetic olivanic acid analogues.
    Basker MJ; Boon RJ; Box SJ; Brown AG; Davis P; Ponsford RJ; Southgate R; Spear SR
    J Antibiot (Tokyo); 1983 Oct; 36(10):1357-71. PubMed ID: 6643283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on monocyclic beta-lactam antibiotics. II. Synthesis and antibacterial activity of 3-acylamino-2-azetidinone-1-oxysulfonic acids.
    Yoshida C; Hori T; Momonoi K; Nagumo K; Nakano J; Kitani T; Fukuoka Y; Saikawa I
    J Antibiot (Tokyo); 1985 Nov; 38(11):1536-49. PubMed ID: 4077733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of an oral penem, Sch 29482.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():49-57. PubMed ID: 6977533
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K; Harada S; Shinagawa S; Imada A; Kuno M
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.
    Weaver SS; Bodey GP; LeBlanc BM
    Antimicrob Agents Chemother; 1979 Apr; 15(4):518-21. PubMed ID: 380462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure activity relationships among the monobactams.
    Bonner DP; Sykes RB
    J Antimicrob Chemother; 1984 Oct; 14(4):313-27. PubMed ID: 6389473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. III. Structure-activity relationships of the 5-membered heterocyclic derivatives.
    Bennett I; Broom NJ; Bruton G; Calvert S; Clarke BP; Coleman K; Edmondson R; Edwards P; Jones D; Osborne NF
    J Antibiot (Tokyo); 1991 Mar; 44(3):331-7. PubMed ID: 2026558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E; Komoto E; Taniyama Y; Mitsuhashi S
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
    Aswapokee N; Neu HC
    J Antibiot (Tokyo); 1978 Dec; 31(12):1238-44. PubMed ID: 310815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.